Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7722
|
pubmed:dateCreated |
1971-10-30
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
28
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
462-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:4105330-Humans,
pubmed-meshheading:4105330-Hyperparathyroidism, Secondary,
pubmed-meshheading:4105330-Kidney Failure, Chronic,
pubmed-meshheading:4105330-Magnesium,
pubmed-meshheading:4105330-Parathyroid Hormone,
pubmed-meshheading:4105330-Renal Dialysis,
pubmed-meshheading:4105330-Time Factors
|
pubmed:year |
1971
|
pubmed:articleTitle |
Effects of magnesium on parathyroid hormone secretion during chronic haemodialysis.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|